TERM ID="NYU_TERM_1" STRING="Additional epidemiological" FREQUENCY=1 START=1219 END=1245 LEMMA="ADDITIONAL EPIDEMIOLOGICAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="Carboxylated proteins" FREQUENCY=1 START=467 END=488 LEMMA="CARBOXYLATED PROTEIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="OA" FREQUENCY=3 START=107 END=109 LEMMA="ORAL ANTICOAGULANTS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_4" STRING="OA" FREQUENCY=3 START=1021 END=1023 LEMMA="ORAL ANTICOAGULANTS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_5" STRING="OA" FREQUENCY=3 START=1199 END=1201 LEMMA="ORAL ANTICOAGULANTS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_6" STRING="OC" FREQUENCY=1 START=307 END=309 LEMMA="OSTEOCALCIN" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_7" STRING="Osteocalcin" FREQUENCY=2 START=294 END=305 LEMMA="OSTEOCALCIN" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_8" STRING="Osteocalcin" FREQUENCY=2 START=294 END=305 LEMMA="OSTEOCALCIN" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_9" STRING="Skeletal effects" FREQUENCY=1 START=0 END=16 LEMMA="SKELETAL EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="Skeletal effects of oral anticoagulants Vitamin K antagonists" FREQUENCY=1 START=0 END=61 LEMMA="ORAL ANTICOAGULANTS VITAMIN K ANTAGONIST SKELETAL EFFECT" LEMMA_FREQUENCY=1 HEAD_TERM="Skeletal effects" HEAD_LEMMA="SKELETAL EFFECT"
TERM ID="NYU_TERM_11" STRING="VKA" FREQUENCY=2 START=63 END=66 LEMMA="VITAMIN K ANTAGONISTS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_12" STRING="VKA" FREQUENCY=2 START=1345 END=1348 LEMMA="VITAMIN K ANTAGONISTS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_13" STRING="Vitamin K antagonists" FREQUENCY=1 START=40 END=61 LEMMA="VITAMIN K ANTAGONIST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="affinity" FREQUENCY=1 START=501 END=509 LEMMA="AFFINITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="affinity for calcium" FREQUENCY=1 START=501 END=521 LEMMA="CALCIUM AFFINITY" LEMMA_FREQUENCY=1 HEAD_TERM="affinity" HEAD_LEMMA="AFFINITY"
TERM ID="NYU_TERM_16" STRING="bone resorption" FREQUENCY=1 START=183 END=198 LEMMA="BONE RESORPTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="calcium" FREQUENCY=2 START=514 END=521 LEMMA="CALCIUM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_18" STRING="calcium" FREQUENCY=2 START=564 END=571 LEMMA="CALCIUM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_19" STRING="clinical consequences" FREQUENCY=1 START=1377 END=1398 LEMMA="CLINICAL CONSEQUENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="co-factor" FREQUENCY=1 START=218 END=227 LEMMA="CO-FACTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="cohort studies" FREQUENCY=1 START=1249 END=1263 LEMMA="COHORT STUDY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="contradictory results" FREQUENCY=1 START=748 END=769 LEMMA="CONTRADICTORY RESULT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="epidemiologic studies" FREQUENCY=2 START=800 END=821 LEMMA="EPIDEMIOLOGIC STUDY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_24" STRING="epidemiologic studies" FREQUENCY=2 START=972 END=993 LEMMA="EPIDEMIOLOGIC STUDY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_25" STRING="fracture" FREQUENCY=1 START=730 END=738 LEMMA="FRACTURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="fracture risk" FREQUENCY=1 START=1080 END=1093 LEMMA="FRACTURE RISK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="hydroxycoumarins" FREQUENCY=1 START=902 END=918 LEMMA="HYDROXYCOUMARIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="incorporation" FREQUENCY=1 START=547 END=560 LEMMA="INCORPORATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="incorporation of calcium" FREQUENCY=1 START=547 END=571 LEMMA="CALCIUM INCORPORATION" LEMMA_FREQUENCY=1 HEAD_TERM="incorporation" HEAD_LEMMA="INCORPORATION"
TERM ID="NYU_TERM_30" STRING="oral anticoagulants" FREQUENCY=2 START=86 END=105 LEMMA="ORAL ANTICOAGULANT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_31" STRING="oral anticoagulants" FREQUENCY=2 START=86 END=105 LEMMA="ORAL ANTICOAGULANT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_32" STRING="oral anticoagulants Vitamin K antagonists" FREQUENCY=1 START=20 END=61 LEMMA="ORAL ANTICOAGULANTS VITAMIN K ANTAGONIST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="osteoblasts" FREQUENCY=1 START=376 END=387 LEMMA="OSTEOBLAST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="physical illnesses" FREQUENCY=1 START=1170 END=1188 LEMMA="PHYSICAL ILLNESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_35" STRING="post-translational carboxylation" FREQUENCY=1 START=235 END=267 LEMMA="POST-TRANSLATIONAL CARBOXYLATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="potential pharmacological effects" FREQUENCY=1 START=1308 END=1341 LEMMA="POTENTIAL PHARMACOLOGICAL EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_37" STRING="potential pharmacological effects of VKA" FREQUENCY=1 START=1308 END=1348 LEMMA="VITAMIN K ANTAGONISTS POTENTIAL PHARMACOLOGICAL EFFECT" LEMMA_FREQUENCY=1 HEAD_TERM="potential pharmacological effects" HEAD_LEMMA="POTENTIAL PHARMACOLOGICAL EFFECT"
TERM ID="NYU_TERM_38" STRING="thromboembolic diseases" FREQUENCY=1 START=131 END=154 LEMMA="THROMBOEMBOLIC DISEASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_39" STRING="undercarboxylated osteocalcin" FREQUENCY=1 START=626 END=655 LEMMA="UNDERCARBOXYLATED OSTEOCALCIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_40" STRING="vitamin K" FREQUENCY=1 START=165 END=174 LEMMA="VITAMIN K" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_41" STRING="vitamin K deficiency" FREQUENCY=1 START=869 END=889 LEMMA="VITAMIN K DEFICIENCY" LEMMA_FREQUENCY=1
